Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.
Telix Pharmaceuticals is seeking a Medical Writer to support international rollout of a prostate cancer imaging agent. The role involves leading the writing process for all phases of clinical drug development, including regulatory documents, clinical study reports, and safety narratives. This position focuses on analyzing scientific data and contributing to strategic goals, aiming to improve quality of life for cancer and rare disease patients.
Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.